GEODE CAPITAL MANAGEMENT, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$54,572
-27.1%
20,9090.0%0.00%
Q2 2023$74,854
+89.4%
20,909
+15.3%
0.00%
Q1 2023$39,523
+18029.8%
18,1300.0%0.00%
Q4 2022$218
-99.8%
18,1300.0%0.00%
Q3 2022$117,000
+41.0%
18,1300.0%0.00%
Q2 2022$83,000
-97.0%
18,130
-94.4%
0.00%
Q1 2022$2,778,000
-20.7%
321,159
+30.9%
0.00%
Q4 2021$3,503,000
-35.5%
245,345
-0.7%
0.00%
-100.0%
Q3 2021$5,428,000
+86.4%
246,971
+13.4%
0.00%
Q2 2021$2,912,000
+1593.0%
217,708
+1183.9%
0.00%
Q1 2021$172,000
+142.3%
16,9570.0%0.00%
Q4 2020$71,000
+61.4%
16,9570.0%0.00%
Q3 2020$44,000
-25.4%
16,9570.0%0.00%
Q2 2020$59,000
+15.7%
16,9570.0%0.00%
Q1 2020$51,000
-70.7%
16,957
-50.0%
0.00%
Q4 2019$174,000
+222.2%
33,914
+100.0%
0.00%
Q3 2019$54,000
-10.0%
16,9570.0%0.00%
Q2 2019$60,00016,9570.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders